Carregant...
The development of an effective synthetic route of lesinurad (RDEA594)
BACKGROUND: Lesinurad is a novel selective uric acid salt transport protein 1 (URAT1) inhibitor which is approved in the USA for the treatment of gout. However, there are some shortcomings among the reported synthetic routes, such as expensive materials, environmental pollution and poor yield. RESUL...
Guardat en:
| Publicat a: | Chem Cent J |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5583131/ https://ncbi.nlm.nih.gov/pubmed/29086884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-017-0316-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|